Innovative Technologies Impacted by COVID–19 Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Dec 14, 2022)
Innovative Technologies Impacted by COVID-19 Act
This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
What just happenedDec 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who’s behind it
- Introduced in HouseDec 14, 2022
- Dec 14, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Dec 14, 2022IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Dec 14, 2022IntroReferralIntro-H
Introduced in House
- Dec 14, 2022IntroReferral1000
Introduced in House